Ophtha Fund
10+Portfolio
Early‑stage investors focused on the future of ophthalmology and life sciences, collaborating with partners to support and guide top companies in the ophthalmic industry.
Where they invest
Geography
Portfolio footprintHover a country to explore
- United States of America
- 66.7%
- Switzerland
- 11.1%
Darker countries represent a larger share of the portfolio.
What they back
Industries
- Biotechnology
- 66.7%
- Applications
- 22.2%
- Artificial Intelligence
- 11.1%
- Digital Health
- 11.1%
- Education Technology
- 11.1%
- Wellness & Fitness Technology
- 11.1%
% of all portfolio companies. Industry categories can overlap.
Stages
Stage indicator
No stages listed